Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Semon, Julie A ^a   Maness, Catherine ^b   Zhang, Xiujuan ^a   Sharkey, Steven A ^a   Beuttler, Marc M ^a   Shah, Forum S ^c   Pandey, Amitabh C ^a   Gimble, Jeffrey M ^c   Zhang, Shijia ^a   Scruggs, Brittni A ^a   Strong, Amy L ^a   Strong, Thomas A ^a   Bunnell, Bruce A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ADIPOSE TISSUE; ADULT STEM CELL; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PATHOLOGY; PROCEDURES; SPINAL CORD; TRANSPLANTATION;

ADIPOSE TISSUE; ADULT STEM CELLS; ANIMALS; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; SPINAL CORD;

EID: 84892174799     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt391     Document Type: Article

References (58)

1. 'Stemness' does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Prockop DJ, Clin Pharmacol Ther 2007 82 241 243 10.1038/sj.clpt.6100313 17700588 (Pubitemid 47258475)
2. Mesenchymal stem cells in health and disease. Uccelli A, Moretta L, Pistoia V, Nat Rev Immunol 2008 8 726 736 10.1038/nri2395 19172693
3. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, Stem Cells 2006 24 1294 1301 10.1634/stemcells.2005-0342 16410387 (Pubitemid 44464698)
4. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD, Exp Hematol 2005 33 1402 1416 10.1016/j.exphem.2005.07.003 16263424 (Pubitemid 41541969)
5. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T, Arthritis Rheum 2005 52 2521 2529 10.1002/art.21212 16052568 (Pubitemid 41117441)
6. Cell growth characteristics, differentiation frequency, and immunophenotype of adult ear mesenchymal stem cells. Staszkiewicz J, Frazier TP, Rowan BG, Bunnell BA, Chiu ES, Gimble JM, Gawronska-Kozak B, Stem Cells Dev 2010 19 83 92 10.1089/scd.2009.0051 19400629
7. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Boquest AC, Shahdadfar A, Frønsdal K, Sigurjonsson O, Tunheim SH, Collas P, Brinchmann JE, Mol Biol Cell 2005 16 1131 1141 10.1091/mbc.E04-10-0949 15635089 (Pubitemid 40349551)
8. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Caplan A, J Cell Physiol 2007 213 341 347 10.1002/jcp.21200 17620285 (Pubitemid 47509711)
9. Mesenchymal stem cells: the past, the present, the future. Caplan A, Cartilage 2010 1 6 9 10.1177/1947603509354992
10. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, Obenauf AC, Lanzer G, Linkesch W, Strunk D, Tissue Eng Part C Methods 2008 14 185 196 10.1089/ten.tec.2008.0060 18620484
11. Stem cells: potential therapy for age-related diseases. Kassem M, Ann N Y Acad Sci 1967 2006 436 442
12. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Izadpanah R, Kaushal D, Kriedt C, Tsien F, Patel B, Dufour J, Bunnell BA, Cancer Res 2008 68 4229 4238 10.1158/0008-5472.CAN-07-5272 18519682
13. Clinical grade production of mesenchymal stem cells. Sensebe L, BioMed Mater Eng 2008 18 3 10
14. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ, Stem Cells 2002 20 530 541 10.1634/stemcells.20-6-530 12456961 (Pubitemid 35463066)
15. Expansion of mesenchymal stem/stromal cells under xonogenic-free culture conditions. Kinzebach S, Bieback K, Adv Biochem Eng Biotechnol 2013 129 33 57 22777242
16. Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Jung S, Panchalingam KM, Rosenberg L, Behie LA, Stem Cells Int 2012 2012 123030 22645619
17. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, Hsu SC, Smith J, Prockop DJ, Mol Ther 2004 9 747 756 10.1016/j.ymthe.2004.02.012 15120336 (Pubitemid 38660428)
18. Methods for growth of cultured cells in serum-free medium. Barnes D, Sato G, Anal Biochem 1980 102 255 270 10.1016/0003-2697(80)90151-7 6999941 (Pubitemid 10115790)
19. 'Humanized' stem cell culture techniques: the animal serum controversy. Tekkatte C, Gunasingh GP, Cherian KM, Sankaranarayanan K, Stem Cells Int 2011 2011 504723 21603148
20. Chemically defined medium for human mesenchymal stem cells. Marshak DR, Holecek JJ, United States Patent 1999 5 908,782
21. Low serum and serum-free culture of multipotential human adipose stem cells. Parker AM, Shang H, Khurgel M, Katz AJ, Cytotherapy 2007 9 637 646 10.1080/14653240701508452 17917877 (Pubitemid 47604653)
22. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Castro-Malaspina H, Gay RE, Resnick G, Blood 1980 56 289 301 6994839 (Pubitemid 10043431)
23. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ, Br J Haematol 1999 107 275 281 10.1046/j.1365-2141.1999. 01715.x 10583212 (Pubitemid 29530211)
24. Large-scale production of human adipose tissue from stem cells: a new tool for regenerative medicine and tissue banking. D'Andrea F, De Francesco F, Ferraro GA, Desiderio V, De Rosa A, Papaccio G, Tissue Eng Part C Methods 2008 14 233 242 10.1089/ten.tec.2008.0108 18781836
25. Adipose tissue-derived cells: from physiology to regenerative medicine. Casteilla L, Dani C, Diabetes Metab 2006 32 393 401 10.1016/S1262-3636(07)70297- 5 17110894 (Pubitemid 44836582)
26. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, Ludlow JW, Stricker DM, Potiny S, Green P, Halvorsen YD, Cheatham B, Storms RW, Gimble JM, J Cell Physiol 2007 212 702 709 10.1002/jcp.21068 17477371 (Pubitemid 47271882)
27. Human adipose tissue is a source of multipotent stem cells. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH, Mol Biol Cell 2002 13 4279 4295 10.1091/mbc.E02-02-0105 12475952 (Pubitemid 35471185)
28. Comparison of multi-lineage cells from human adipose tissue and bone marrow. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashijian P, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH, Cells Tissues Organs 2003 174 101 109 10.1159/000071150 12835573 (Pubitemid 36819010)
29. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA, J Cell Biochem 2006 99 1285 1297 10.1002/jcb.20904 16795045
30. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B, J Transl Med 2009 7 29 10.1186/1479-5876-7-29 19393041
31. Gender differences in self-reported symptom awareness and perceived ability to manage therapy with disease-modifying medication among commercially insured multiple sclerosis patients. Vlahiotis A, Sedjo R, Cox ER, Burroughs TE, Rauchway A, Lick R, J Manag Care Pharm 2010 16 206 216 20331325
32. MS Disease-modifying Medications. [ http://www.nationalmssociety.org/ about-multiple-sclerosis/what-we-know-about-ms/treatments/index.aspx ]
33. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, Gini B, Bach SD, Martinello M, Bifari F, Gallie M, Turano E, Budui S, Sbarbati A, Krampera M, Bonetti B, Stem Cells 2009 27 2624 2635 10.1002/stem.194 19676124
34. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, Di Halvorsen Y, Storms RW, Goh B, Kilroy G, Wu X, Gimble JM, Stem Cells 2006 24 376 385 10.1634/stemcells.2005- 0234 16322640 (Pubitemid 44464807)
35. Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyzes. Yu G, Wu X, Dietrich MA, Polk P, Scott LK, Ptitsyn AA, Gimble JM, Cytotherapy 2010 12 538 546 10.3109/14653241003649528 20380539
36. Yield of human adipose-derived adult stem cells from liposuction aspirates. Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, Sen A, Willingmyre GD, Gimble JM, Cytotherapy 2004 6 7 14 10.1080/14653240310004539 14985162 (Pubitemid 38325114)
37. Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis. Chen SJ, Wang YL, Fan HC, Lo WT, Wang CC, Sytwu HK, Clin Dev Immunol 2012 2012 1 16
38. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Reynolds JM, Martinez GJ, Chung Y, Dong C, Proc Natl Acad Sci U S A 2012 109 13064 13069 10.1073/pnas.1120585109 22826216
39. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A, Blood 2005 106 1755 1761 10.1182/blood-2005-04-1496 15905186 (Pubitemid 41208591)
40. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D, Arch Neurol 2008 65 753 761 18541795 (Pubitemid 351831453)
41. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, Mantgazza R, Frassoni F, Mancardi G, Pedotti R, Uccelli A, Ann Neurol 2007 3 219 227 (Pubitemid 46557346)
42. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Gimble JM, Guilak F, Bunnell BA, Stem Cell Res Ther 2010 1 19 10.1186/scrt19 20587076
43. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Schäffler A, Büchler C, Stem Cells 2007 25 818 827 10.1634/stemcells.2006-0589 17420225 (Pubitemid 46572577)
44. Adipose-derived stromal cells-their utility and potential in bone formation. Halvorsen YC, Wilkison WO, Gimble JM, Int J Obes Relat Metab Disord 2000 24 41 44
45. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Rangappa S, Fen C, Lee EH, Bongso A, Sim EK, Ann Thorac Surg 2003 75 775 779 10.1016/S0003-4975(02)04568-X 12645692 (Pubitemid 36298339)
46. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L, Casteilla L, Circulation 2004 109 656 663 10.1161/01.CIR.0000114522.38265.61 14734516 (Pubitemid 38198874)
47. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Tran TT, Kahn CR, Nat Rev Endocrinol 2010 6 195 213 10.1038/nrendo.2010.20 20195269
48. Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity. Peinado JR, Pardo M, de la Rosa O, Malagon MM, Proteomics 2012 12 607 620 10.1002/pmic.201100355 22246603
49. Techniques for studying adipocytes. Hausman GJ, Stain Technol 1981 56 149 154 6168034 (Pubitemid 11059336)
50. Cells in human adipose tissue developing into adipocytes. Pettersson P, Cigolini M, Sjöström L, Smith U, Björntorp P, Acta Med Scand 1984 215 447 451 6741607 (Pubitemid 14083747)
51. Adipose tissues as an ancestral immune organ: site-specific change in obesity. Caspar-Bauguil S, Cousin B, Galinier A, Segafredo C, Nibbelink M, Andre M, Casteilla L, Penicaud L, FEBS Lett 2005 579 3487 3492 10.1016/j.febslet. 2005.05.031 15953605 (Pubitemid 40897681)
52. Plasticity of adipose tissue: a promising therapeutic avenue in the treatment of cardiovascular and blood diseases? Casteilla L, Planat-Bénard V, Cousin B, Silvestre JS, Laharrague P, Charriere G, Carriere A, Penicaud L, Arch Mal Coeur Vaiss 2005 98 922 926 16231580
53. Obesity is associated with macrophage accumulation in adipose tissue. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr, J Clin Invest 2003 112 1796 1808 14679176 (Pubitemid 38063703)
54. Administration of murine stromal vascular fraction ameliorates chronic experimental autoimmune encephalomyelitis. Semon JA, Zhang X, Pandey AC, Alandete SM, Maness C, Zhang S, Scruggs BA, Strong AL, Sharkey SA, Beuttler MM, Gimble JM, Bunnell BA, Stem Cells Trans Med 2013 2 789 96 10.5966/sctm.2013-0032
55. Multilineage cells from human adipose tissue: implications for cell-based therapies. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hendrick MH, Tissue Eng 2001 7 211 228 10.1089/107632701300062859 11304456 (Pubitemid 32295155)
56. Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. Han KH, Ro H, Hong JH, Lee EM, Cho B, Yeom HJ, Kim MG, Oh KH, Ahn C, Yang J, Transpl Immunol 2011 1 7 15
57. Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro. Wehner R, Taubert C, Mende T, Gaebler C, de Andrade AV, Bornhauser M, Werner C, Tonn T, Schakel K, Bachman M, Schmitz M, J Tissue Eng Regen Med 2012 7 921 924
58. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation. Carrión F, Nova E, Luz P, Apablaza F, Figueroa F, Immunol Lett 2011 135 10 16 10.1016/j.imlet.2010.09.006 20888363